← Leaderboards
Nicolas Augusto Bamat
Children'S Hosp Of Philadelphia
$791,640
Attributed
$791,640
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $158.3K · FY2020–24$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$791,640 · 1
By mechanism
K23$791,640 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Erik Allen Jensen$3,441,542
- Sara Bonamo Demauro$17,178,971
- Susan Hintz$556,797
- Stephen Paridon$1,749,233
- James William Gaynor$5,405,569
Others in their field
Other Emerging Leaders on “Absorption”
- Aina E. Cohen · Stanford University$10,909,501
- Anna Upton · Global Alliance For Tb Drug Development$10,496,979
- Deborah Bunin · Sri International$10,209,148
- Jay Evans · University Of Montana$9,566,206
- Christian Arthur Heidbreder · Indivior, Inc.$8,445,278
- Richard Joseph Johnson · Colorado Research Partners, Llc$6,102,731
Research focus
AbsorptionAdverse EffectsAnimal DataAwardBiological AvailabilityBloodBronchopulmonary DysplasiaCareerCareer DevelopmentCaringCessation Of LifeChildhoodChronicChronic Lung DiseaseClinical EfficacyClinical InvestigatorClinical PharmacologyClinical ResearchClinical TrialsComorbidityComparative EffectivenessComplexData AnalysesDesign
Grant awards (5)
Furosemide in severe bronchopulmonary dysplasia: comparative effectiveness of a duration and dosage informed treatment strategy$158,328
K23 · FY2024 · HD · contact PI
Furosemide in severe bronchopulmonary dysplasia: comparative effectiveness of a duration and dosage informed treatment strategy$158,328
K23 · FY2023 · HD · contact PI
Furosemide in severe bronchopulmonary dysplasia: comparative effectiveness of a duration and dosage informed treatment strategy$158,328
K23 · FY2022 · HD · contact PI
Furosemide in severe bronchopulmonary dysplasia: comparative effectiveness of a duration and dosage informed treatment strategy$158,328
K23 · FY2021 · HD · contact PI
Furosemide in severe bronchopulmonary dysplasia: comparative effectiveness of a duration and dosage informed treatment strategy$158,328
K23 · FY2020 · HD · contact PI